Country: United States
Language: English
Source: NLM (National Library of Medicine)
CHLOROPROCAINE HYDROCHLORIDE (UNII: LT7Z1YW11H) (CHLOROPROCAINE - UNII:5YVB0POT2H)
Hikma Pharmaceuticals USA Inc.
CHLOROPROCAINE HYDROCHLORIDE
CHLOROPROCAINE HYDROCHLORIDE 20 mg in 1 mL
EPIDURAL
PRESCRIPTION DRUG
Chloroprocaine hydrochloride injection 2% and 3%, in single dose vials, without methylparaben preservative, without EDTA, is indicated for the production of local anesthesia by infiltration, peripheral and central nerve block, including lumbar and caudal epidural blocks. Chloroprocaine hydrochloride injection is not to be used for subarachnoid administration. Chloroprocaine hydrochloride is contraindicated in patients hypersensitive (allergic) to drugs of the PABA ester group. Lumbar and caudal epidural anesthesia should be used with extreme caution in persons with the following conditions: existing neurological disease, spinal deformities, septicemia, and severe hypertension.
Chloroprocaine Hydrochloride Injection, USP, without preservatives and without EDTA, is supplied as follows: 3% solution (NDC 0143-9210-10 ) in 20 mL single dose vials, packaged 10 vials per carton. 2% solution (NDC 0143-9209-10 ) in 20 mL single dose vials, packaged 10 vials per carton. Keep from freezing. Protect from light. Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. To report SUSPECTED ADVERSE REACTIONS, contact Hikma Pharmaceuticals USA Inc. at 1-877-845-0689, or the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch . For Product Inquiry call 1-877-845-0689.
Abbreviated New Drug Application
CHLOROPROCAINE HYDROCHLORIDE- CHLOROPROCAINE HYDROCHLORIDE INJECTION, SOLUTION HIKMA PHARMACEUTICALS USA INC. ---------- CHLOROPROCAINE HYDROCHLORIDE INJECTION, USP FOR INFILTRATION AND NERVE BLOCK RX ONLY DESCRIPTION Chloroprocaine Hydrochloride Injection, USP is a sterile non-pyrogenic local anesthetic. The active ingredient is chloroprocaine HCl (benzoic acid, 4-amino-2-chloro-2- (diethylamino) ethyl ester, monohydrochloride), which is represented by the following structural formula: Molecular Formula: C H ClN O • HCl M. W. 307.22 Chloroprocaine Hydrochloride Injection, USP is available in a 2% and 3% solution for infiltration, nerve block, caudal and epidural anesthesia (NOT for spinal anesthesia). Each mL of the 20 mg/mL, 2%, solution contains; 20 mg of Chloroprocaine HCl, USP, 4.7 mg of Sodium Chloride, USP, and Sodium Hydroxide and/or Hydrochloric Acid to adjust pH. The pH range is 2.7 to 4.0. Each mL of the 30 mg/mL, 3%, solution contains; 30 mg of Chloroprocaine HCl, USP, 3.3 mg of Sodium Chloride, USP, and Sodium Hydroxide and/or Hydrochloric Acid to adjust pH. The pH range is 2.7 to 4.0. Chloroprocaine HCl Injection, USP, should not be resterilized by autoclaving. CLINICAL PHARMACOLOGY Chloroprocaine, like other local anesthetics, blocks the generation and the conduction of nerve impulses, presumably by increasing the threshold for electrical excitation in the nerve, by slowing the propagation of the nerve impulse and by reducing the rate of rise of the action potential. In general, the progression of anesthesia is related to the diameter, myelination and conduction velocity of affected nerve fibers. Clinically, the order of loss of nerve function is as follows: (1) pain, (2) temperature, (3) touch, (4) proprioception, and (5) skeletal muscle tone. 13 19 2 2 Systemic absorption of local anesthetics produces effects on the cardiovascular and central nervous systems. At blood concentrations achieved with normal therapeutic doses, changes in cardiac conduction, excitability, refractoriness, contractilit Read the complete document